Cargando…
The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function
RATIONALE: Nicotine has been widely studied for its pro-dopaminergic effects. However, at the behavioural level, past investigations have yielded heterogeneous results concerning effects on cognitive, affective, and motor outcomes, possibly linked to individual differences at the level of genetics....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638222/ https://www.ncbi.nlm.nih.gov/pubmed/34854936 http://dx.doi.org/10.1007/s00213-021-06028-x |
_version_ | 1784608908127502336 |
---|---|
author | Schröder, Rebekka Reuter, Martin Faßbender, Kaja Plieger, Thomas Poulsen, Jessie Lui, Simon S. Y. Chan, Raymond C. K. Ettinger, Ulrich |
author_facet | Schröder, Rebekka Reuter, Martin Faßbender, Kaja Plieger, Thomas Poulsen, Jessie Lui, Simon S. Y. Chan, Raymond C. K. Ettinger, Ulrich |
author_sort | Schröder, Rebekka |
collection | PubMed |
description | RATIONALE: Nicotine has been widely studied for its pro-dopaminergic effects. However, at the behavioural level, past investigations have yielded heterogeneous results concerning effects on cognitive, affective, and motor outcomes, possibly linked to individual differences at the level of genetics. A candidate polymorphism is the 40-base-pair variable number of tandem repeats polymorphism (rs28363170) in the SLC6A3 gene coding for the dopamine transporter (DAT). The polymorphism has been associated with striatal DAT availability (9R-carriers > 10R-homozygotes), and 9R-carriers have been shown to react more strongly to dopamine agonistic pharmacological challenges than 10R-homozygotes. OBJECTIVES: In this preregistered study, we hypothesized that 9R-carriers would be more responsive to nicotine due to genotype-related differences in DAT availability and resulting dopamine activity. METHODS: N=194 non-smokers were grouped according to their genotype (9R-carriers, 10R-homozygotes) and received either 2-mg nicotine or placebo gum in a between-subject design. Spontaneous blink rate (SBR) was obtained as an indirect measure of striatal dopamine activity and smooth pursuit, stop signal, simple choice and affective processing tasks were carried out in randomized order. RESULTS: Reaction times were decreased under nicotine compared to placebo in the simple choice and stop signal tasks, but nicotine and genotype had no effects on any of the other task outcomes. Conditional process analyses testing the mediating effect of SBR on performance and how this is affected by genotype yielded no significant results. CONCLUSIONS: Overall, we could not confirm our main hypothesis. Individual differences in nicotine response could not be explained by rs28363170 genotype. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00213-021-06028-x. |
format | Online Article Text |
id | pubmed-8638222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-86382222021-12-03 The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function Schröder, Rebekka Reuter, Martin Faßbender, Kaja Plieger, Thomas Poulsen, Jessie Lui, Simon S. Y. Chan, Raymond C. K. Ettinger, Ulrich Psychopharmacology (Berl) Original Investigation RATIONALE: Nicotine has been widely studied for its pro-dopaminergic effects. However, at the behavioural level, past investigations have yielded heterogeneous results concerning effects on cognitive, affective, and motor outcomes, possibly linked to individual differences at the level of genetics. A candidate polymorphism is the 40-base-pair variable number of tandem repeats polymorphism (rs28363170) in the SLC6A3 gene coding for the dopamine transporter (DAT). The polymorphism has been associated with striatal DAT availability (9R-carriers > 10R-homozygotes), and 9R-carriers have been shown to react more strongly to dopamine agonistic pharmacological challenges than 10R-homozygotes. OBJECTIVES: In this preregistered study, we hypothesized that 9R-carriers would be more responsive to nicotine due to genotype-related differences in DAT availability and resulting dopamine activity. METHODS: N=194 non-smokers were grouped according to their genotype (9R-carriers, 10R-homozygotes) and received either 2-mg nicotine or placebo gum in a between-subject design. Spontaneous blink rate (SBR) was obtained as an indirect measure of striatal dopamine activity and smooth pursuit, stop signal, simple choice and affective processing tasks were carried out in randomized order. RESULTS: Reaction times were decreased under nicotine compared to placebo in the simple choice and stop signal tasks, but nicotine and genotype had no effects on any of the other task outcomes. Conditional process analyses testing the mediating effect of SBR on performance and how this is affected by genotype yielded no significant results. CONCLUSIONS: Overall, we could not confirm our main hypothesis. Individual differences in nicotine response could not be explained by rs28363170 genotype. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00213-021-06028-x. Springer Berlin Heidelberg 2021-12-02 2022 /pmc/articles/PMC8638222/ /pubmed/34854936 http://dx.doi.org/10.1007/s00213-021-06028-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Investigation Schröder, Rebekka Reuter, Martin Faßbender, Kaja Plieger, Thomas Poulsen, Jessie Lui, Simon S. Y. Chan, Raymond C. K. Ettinger, Ulrich The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function |
title | The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function |
title_full | The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function |
title_fullStr | The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function |
title_full_unstemmed | The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function |
title_short | The role of the SLC6A3 3’ UTR VNTR in nicotine effects on cognitive, affective, and motor function |
title_sort | role of the slc6a3 3’ utr vntr in nicotine effects on cognitive, affective, and motor function |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638222/ https://www.ncbi.nlm.nih.gov/pubmed/34854936 http://dx.doi.org/10.1007/s00213-021-06028-x |
work_keys_str_mv | AT schroderrebekka theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT reutermartin theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT faßbenderkaja theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT pliegerthomas theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT poulsenjessie theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT luisimonsy theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT chanraymondck theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT ettingerulrich theroleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT schroderrebekka roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT reutermartin roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT faßbenderkaja roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT pliegerthomas roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT poulsenjessie roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT luisimonsy roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT chanraymondck roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction AT ettingerulrich roleoftheslc6a33utrvntrinnicotineeffectsoncognitiveaffectiveandmotorfunction |